PKBDO6920YKFO
PKBDO6920YKFO
released
Clinical summary
Diabetes status
Type 1 Diabetes
BMI
37.1
HbA1c %
7.6
C-Peptide (ng/ml)
0.05
Diabetes duration
20
Demographics
- Age (y)
- 37
- Gender
- Male
- Ethnicity
- White
Additional clinical
- Diabetes (ontology)
- T1D stage
- Stage 3: one or more autoantibodies and diagnostic hyperglycemia or T1D diagnosis
- Derived diabetes status
- Diabetes
- Living donor
- No
- Cause of death
- Anoxia
- Hospital stay (h)
- 102
Autoantibodies
GADAPositive
No value
1
IAANegative
No value
IA2Negative
No value
ZNT8Negative
No value
HLA typing
| Locus | Allele 1 | Allele 2 | Method |
|---|---|---|---|
| A | 24:02 | 29:02 | NGS |
| B | — | — | NGS |
| C | — | — | NGS |
| DRB1 | 03:01 | 07:01 | NGS |
| DQA1 | 02:01 | 05:01 | NGS |
| DQB1 | 02:01 | 02:02 | NGS |
| DPA1 | — | — | NGS |
| DPB1 | — | — | NGS |
Supplementary
nPOD
nPOD_portal:6281
- Pancreas tissue available
- Yes
- Other tissues
- —
Attribution
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
